USA Biopharmaceutical Cmo & Cro Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Biopharmaceutical Cmo & Cro market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Biopharmaceutical Cmo & Cro market. Detailed analysis of key players, along with key growth strategies adopted by Biopharmaceutical Cmo & Cro industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Lonza

    • Binex Co, Ltd

    • ProBioGen

    • BIOMEVA GmbH

    • TOYOBO CO, LTD

    • Samsung BioLogics

    • JRS Pharma (Celonic GmbH)

    • WuXi Biologics

    • Patheon

    • AbbVie Inc

    • FUJIFILM Diosynth Biotechnologies USA, Inc

    • CMC Biologics

    • Inno Biologics Sdn Bhd

    • Boehringer Ingelheim GmbH

    • Rentschler Biotechnologie GmbH

    By Type:

    • Biologics

    • Biosimilars

    By End-User:

    • Contract Manufacturing

    • Contract Research

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biopharmaceutical Cmo & Cro Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Biopharmaceutical Cmo & Cro Market Size and Growth Rate of Biologics from 2016 to 2027

      • 1.3.2 USA Biopharmaceutical Cmo & Cro Market Size and Growth Rate of Biosimilars from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Biopharmaceutical Cmo & Cro Market Size and Growth Rate of Contract Manufacturing from 2016 to 2027

      • 1.4.2 USA Biopharmaceutical Cmo & Cro Market Size and Growth Rate of Contract Research from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Biopharmaceutical Cmo & Cro Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Biopharmaceutical Cmo & Cro Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Biopharmaceutical Cmo & Cro Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Biopharmaceutical Cmo & Cro Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Biopharmaceutical Cmo & Cro Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biopharmaceutical Cmo & Cro by Major Types

      • 3.4.1 Market Size and Growth Rate of Biologics

      • 3.4.2 Market Size and Growth Rate of Biosimilars

    4 Segmentation of Biopharmaceutical Cmo & Cro Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biopharmaceutical Cmo & Cro by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Biopharmaceutical Cmo & Cro in Contract Manufacturing

      • 4.4.2 Market Size and Growth Rate of Biopharmaceutical Cmo & Cro in Contract Research

    5 Market Analysis by Regions

    • 5.1 USA Biopharmaceutical Cmo & Cro Production Analysis by Regions

    • 5.2 USA Biopharmaceutical Cmo & Cro Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Biopharmaceutical Cmo & Cro Landscape Analysis

    • 6.1 West USA Biopharmaceutical Cmo & Cro Landscape Analysis by Major Types

    • 6.2 West USA Biopharmaceutical Cmo & Cro Landscape Analysis by Major End-Users

    7 South USA Biopharmaceutical Cmo & Cro Landscape Analysis

    • 7.1 South USA Biopharmaceutical Cmo & Cro Landscape Analysis by Major Types

    • 7.2 South USA Biopharmaceutical Cmo & Cro Landscape Analysis by Major End-Users

    8 Middle West USA Biopharmaceutical Cmo & Cro Landscape Analysis

    • 8.1 Middle West USA Biopharmaceutical Cmo & Cro Landscape Analysis by Major Types

    • 8.2 Middle West USA Biopharmaceutical Cmo & Cro Landscape Analysis by Major End-Users

    9 Northeast USA Biopharmaceutical Cmo & Cro Landscape Analysis

    • 9.1 Northeast USA Biopharmaceutical Cmo & Cro Landscape Analysis by Major Types

    • 9.2 Northeast USA Biopharmaceutical Cmo & Cro Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Lonza

        • 10.1.1 Lonza Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Binex Co, Ltd

        • 10.2.1 Binex Co, Ltd Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 ProBioGen

        • 10.3.1 ProBioGen Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 BIOMEVA GmbH

        • 10.4.1 BIOMEVA GmbH Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 TOYOBO CO, LTD

        • 10.5.1 TOYOBO CO, LTD Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Samsung BioLogics

        • 10.6.1 Samsung BioLogics Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 JRS Pharma (Celonic GmbH)

        • 10.7.1 JRS Pharma (Celonic GmbH) Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 WuXi Biologics

        • 10.8.1 WuXi Biologics Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Patheon

        • 10.9.1 Patheon Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 AbbVie Inc

        • 10.10.1 AbbVie Inc Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 FUJIFILM Diosynth Biotechnologies USA, Inc

        • 10.11.1 FUJIFILM Diosynth Biotechnologies USA, Inc Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 CMC Biologics

        • 10.12.1 CMC Biologics Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Inno Biologics Sdn Bhd

        • 10.13.1 Inno Biologics Sdn Bhd Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 Boehringer Ingelheim GmbH

        • 10.14.1 Boehringer Ingelheim GmbH Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 Rentschler Biotechnologie GmbH

        • 10.15.1 Rentschler Biotechnologie GmbH Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Biopharmaceutical Cmo & Cro Market Size and Growth Rate of Biologics from 2016 to 2027

    • Figure USA Biopharmaceutical Cmo & Cro Market Size and Growth Rate of Biosimilars from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Biopharmaceutical Cmo & Cro Market Size and Growth Rate of Contract Manufacturing from 2016 to 2027

    • Figure USA Biopharmaceutical Cmo & Cro Market Size and Growth Rate of Contract Research from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Biopharmaceutical Cmo & Cro Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Biopharmaceutical Cmo & Cro Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Biopharmaceutical Cmo & Cro Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Biopharmaceutical Cmo & Cro Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Biopharmaceutical Cmo & Cro Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Biopharmaceutical Cmo & Cro

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biopharmaceutical Cmo & Cro by Different Types from 2016 to 2027

    • Table Consumption Share of Biopharmaceutical Cmo & Cro by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Biologics

    • Figure Market Size and Growth Rate of Biosimilars

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Biopharmaceutical Cmo & Cro by Different End-Users from 2016 to 2027

    • Table Consumption Share of Biopharmaceutical Cmo & Cro by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Contract Manufacturing

    • Figure Market Size and Growth Rate of Contract Research

    • Table USA Biopharmaceutical Cmo & Cro Production by Regions

    • Table USA Biopharmaceutical Cmo & Cro Production Share by Regions

    • Figure USA Biopharmaceutical Cmo & Cro Production Share by Regions in 2016

    • Figure USA Biopharmaceutical Cmo & Cro Production Share by Regions in 2021

    • Figure USA Biopharmaceutical Cmo & Cro Production Share by Regions in 2027

    • Table USA Biopharmaceutical Cmo & Cro Consumption by Regions

    • Table USA Biopharmaceutical Cmo & Cro Consumption Share by Regions

    • Figure USA Biopharmaceutical Cmo & Cro Consumption Share by Regions in 2016

    • Figure USA Biopharmaceutical Cmo & Cro Consumption Share by Regions in 2021

    • Figure USA Biopharmaceutical Cmo & Cro Consumption Share by Regions in 2027

    • Table West USA Biopharmaceutical Cmo & Cro Consumption by Types from 2016 to 2027

    • Table West USA Biopharmaceutical Cmo & Cro Consumption Share by Types from 2016 to 2027

    • Figure West USA Biopharmaceutical Cmo & Cro Consumption Share by Types in 2016

    • Figure West USA Biopharmaceutical Cmo & Cro Consumption Share by Types in 2021

    • Figure West USA Biopharmaceutical Cmo & Cro Consumption Share by Types in 2027

    • Table West USA Biopharmaceutical Cmo & Cro Consumption by End-Users from 2016 to 2027

    • Table West USA Biopharmaceutical Cmo & Cro Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Biopharmaceutical Cmo & Cro Consumption Share by End-Users in 2016

    • Figure West USA Biopharmaceutical Cmo & Cro Consumption Share by End-Users in 2021

    • Figure West USA Biopharmaceutical Cmo & Cro Consumption Share by End-Users in 2027

    • Table South USA Biopharmaceutical Cmo & Cro Consumption by Types from 2016 to 2027

    • Table South USA Biopharmaceutical Cmo & Cro Consumption Share by Types from 2016 to 2027

    • Figure South USA Biopharmaceutical Cmo & Cro Consumption Share by Types in 2016

    • Figure South USA Biopharmaceutical Cmo & Cro Consumption Share by Types in 2021

    • Figure South USA Biopharmaceutical Cmo & Cro Consumption Share by Types in 2027

    • Table South USA Biopharmaceutical Cmo & Cro Consumption by End-Users from 2016 to 2027

    • Table South USA Biopharmaceutical Cmo & Cro Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Biopharmaceutical Cmo & Cro Consumption Share by End-Users in 2016

    • Figure South USA Biopharmaceutical Cmo & Cro Consumption Share by End-Users in 2021

    • Figure South USA Biopharmaceutical Cmo & Cro Consumption Share by End-Users in 2027

    • Table Middle West USA Biopharmaceutical Cmo & Cro Consumption by Types from 2016 to 2027

    • Table Middle West USA Biopharmaceutical Cmo & Cro Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Biopharmaceutical Cmo & Cro Consumption Share by Types in 2016

    • Figure Middle West USA Biopharmaceutical Cmo & Cro Consumption Share by Types in 2021

    • Figure Middle West USA Biopharmaceutical Cmo & Cro Consumption Share by Types in 2027

    • Table Middle West USA Biopharmaceutical Cmo & Cro Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Biopharmaceutical Cmo & Cro Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Biopharmaceutical Cmo & Cro Consumption Share by End-Users in 2016

    • Figure Middle West USA Biopharmaceutical Cmo & Cro Consumption Share by End-Users in 2021

    • Figure Middle West USA Biopharmaceutical Cmo & Cro Consumption Share by End-Users in 2027

    • Table Northeast USA Biopharmaceutical Cmo & Cro Consumption by Types from 2016 to 2027

    • Table Northeast USA Biopharmaceutical Cmo & Cro Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Biopharmaceutical Cmo & Cro Consumption Share by Types in 2016

    • Figure Northeast USA Biopharmaceutical Cmo & Cro Consumption Share by Types in 2021

    • Figure Northeast USA Biopharmaceutical Cmo & Cro Consumption Share by Types in 2027

    • Table Northeast USA Biopharmaceutical Cmo & Cro Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Biopharmaceutical Cmo & Cro Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Biopharmaceutical Cmo & Cro Consumption Share by End-Users in 2016

    • Figure Northeast USA Biopharmaceutical Cmo & Cro Consumption Share by End-Users in 2021

    • Figure Northeast USA Biopharmaceutical Cmo & Cro Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Lonza

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lonza

    • Figure Sales and Growth Rate Analysis of Lonza

    • Figure Revenue and Market Share Analysis of Lonza

    • Table Product and Service Introduction of Lonza

    • Table Company Profile and Development Status of Binex Co, Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Binex Co, Ltd

    • Figure Sales and Growth Rate Analysis of Binex Co, Ltd

    • Figure Revenue and Market Share Analysis of Binex Co, Ltd

    • Table Product and Service Introduction of Binex Co, Ltd

    • Table Company Profile and Development Status of ProBioGen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ProBioGen

    • Figure Sales and Growth Rate Analysis of ProBioGen

    • Figure Revenue and Market Share Analysis of ProBioGen

    • Table Product and Service Introduction of ProBioGen

    • Table Company Profile and Development Status of BIOMEVA GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOMEVA GmbH

    • Figure Sales and Growth Rate Analysis of BIOMEVA GmbH

    • Figure Revenue and Market Share Analysis of BIOMEVA GmbH

    • Table Product and Service Introduction of BIOMEVA GmbH

    • Table Company Profile and Development Status of TOYOBO CO, LTD

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of TOYOBO CO, LTD

    • Figure Sales and Growth Rate Analysis of TOYOBO CO, LTD

    • Figure Revenue and Market Share Analysis of TOYOBO CO, LTD

    • Table Product and Service Introduction of TOYOBO CO, LTD

    • Table Company Profile and Development Status of Samsung BioLogics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samsung BioLogics

    • Figure Sales and Growth Rate Analysis of Samsung BioLogics

    • Figure Revenue and Market Share Analysis of Samsung BioLogics

    • Table Product and Service Introduction of Samsung BioLogics

    • Table Company Profile and Development Status of JRS Pharma (Celonic GmbH)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of JRS Pharma (Celonic GmbH)

    • Figure Sales and Growth Rate Analysis of JRS Pharma (Celonic GmbH)

    • Figure Revenue and Market Share Analysis of JRS Pharma (Celonic GmbH)

    • Table Product and Service Introduction of JRS Pharma (Celonic GmbH)

    • Table Company Profile and Development Status of WuXi Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of WuXi Biologics

    • Figure Sales and Growth Rate Analysis of WuXi Biologics

    • Figure Revenue and Market Share Analysis of WuXi Biologics

    • Table Product and Service Introduction of WuXi Biologics

    • Table Company Profile and Development Status of Patheon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Patheon

    • Figure Sales and Growth Rate Analysis of Patheon

    • Figure Revenue and Market Share Analysis of Patheon

    • Table Product and Service Introduction of Patheon

    • Table Company Profile and Development Status of AbbVie Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie Inc

    • Figure Sales and Growth Rate Analysis of AbbVie Inc

    • Figure Revenue and Market Share Analysis of AbbVie Inc

    • Table Product and Service Introduction of AbbVie Inc

    • Table Company Profile and Development Status of FUJIFILM Diosynth Biotechnologies USA, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of FUJIFILM Diosynth Biotechnologies USA, Inc

    • Figure Sales and Growth Rate Analysis of FUJIFILM Diosynth Biotechnologies USA, Inc

    • Figure Revenue and Market Share Analysis of FUJIFILM Diosynth Biotechnologies USA, Inc

    • Table Product and Service Introduction of FUJIFILM Diosynth Biotechnologies USA, Inc

    • Table Company Profile and Development Status of CMC Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CMC Biologics

    • Figure Sales and Growth Rate Analysis of CMC Biologics

    • Figure Revenue and Market Share Analysis of CMC Biologics

    • Table Product and Service Introduction of CMC Biologics

    • Table Company Profile and Development Status of Inno Biologics Sdn Bhd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Inno Biologics Sdn Bhd

    • Figure Sales and Growth Rate Analysis of Inno Biologics Sdn Bhd

    • Figure Revenue and Market Share Analysis of Inno Biologics Sdn Bhd

    • Table Product and Service Introduction of Inno Biologics Sdn Bhd

    • Table Company Profile and Development Status of Boehringer Ingelheim GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim GmbH

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim GmbH

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim GmbH

    • Table Product and Service Introduction of Boehringer Ingelheim GmbH

    • Table Company Profile and Development Status of Rentschler Biotechnologie GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Rentschler Biotechnologie GmbH

    • Figure Sales and Growth Rate Analysis of Rentschler Biotechnologie GmbH

    • Figure Revenue and Market Share Analysis of Rentschler Biotechnologie GmbH

    • Table Product and Service Introduction of Rentschler Biotechnologie GmbH


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.